TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Karo Pharma Sverige AB
Closing information (x1000 SEK)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover |
276,924
|
228,725
|
293,539 |
Financial expenses |
345
|
126
|
153 |
Earnings before taxes |
-16,320
|
-12,443
|
-1,062 |
EBITDA |
-15,695
|
-82,259
|
8,375 |
Total assets |
296,323
|
298,767
|
157,642 |
Current assets |
295,600
|
297,645
|
110,036 |
Current liabilities |
80,806
|
66,565
|
112,901 |
Equity capital |
215,517
|
232,096
|
44,635 |
- share capital |
157
![]() |
157
![]() |
157 |
Employees (average) |
129
|
93
|
40 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency |
72.7%
|
77.7%
|
28.3% |
Turnover per employee |
2,147
|
2,459
|
7,338 |
Profit as a percentage of turnover |
-5.9%
|
-5.4%
|
-0.4% |
Return on assets (ROA) |
-5.4%
|
-4.1%
|
-0.6% |
Current ratio |
365.8%
|
447.1%
|
97.5% |
Return on equity (ROE) |
-7.6%
|
-5.4%
|
-2.4% |
Change turnover |
48,199
|
-64,814
|
1,077 |
Change turnover % |
21%
|
-22%
|
0% |
Chg. No. of employees |
36
|
53
|
11 |
Chg. No. of employees % |
39%
|
133%
|
38% |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.